Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

GeneDx Holdings (WGS) Revenue: 2019-2024

Historic Revenue for GeneDx Holdings (WGS) over the last 6 years, with Dec 2024 value amounting to $305.4 million.

  • GeneDx Holdings' Revenue rose 51.86% to $116.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $402.2 million, marking a year-over-year increase of 50.50%. This contributed to the annual value of $305.4 million for FY2024, which is 50.79% up from last year.
  • According to the latest figures from FY2024, GeneDx Holdings' Revenue is $305.4 million, which was up 50.79% from $202.6 million recorded in FY2023.
  • Over the past 5 years, GeneDx Holdings' Revenue peaked at $305.4 million during FY2024, and registered a low of $179.3 million during FY2020.
  • Over the past 3 years, GeneDx Holdings' median Revenue value was $234.7 million (recorded in 2022), while the average stood at $247.6 million.
  • As far as peak fluctuations go, GeneDx Holdings' Revenue fell by 13.69% in 2023, and later skyrocketed by 50.79% in 2024.
  • GeneDx Holdings' Revenue (Yearly) stood at $179.3 million in 2020, then increased by 18.33% to $212.2 million in 2021, then grew by 10.60% to $234.7 million in 2022, then fell by 13.69% to $202.6 million in 2023, then spiked by 50.79% to $305.4 million in 2024.